• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form SC 13G filed by Outbrain Inc.

    2/7/22 3:53:00 PM ET
    $OB
    Computer Software: Programming Data Processing
    Technology
    Get the next $OB alert in real time by email
    SC 13G 1 d307081dsc13g.htm SC 13G SC 13G

     

     

    SECURITIES AND EXCHANGE COMMISSION

    WASHINGTON, D.C. 20549

     

     

    SCHEDULE 13G

    (Rule 13d-102)

    INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT TO § 240.13d-1 (b), (c) AND (d) AND AMENDMENTS THERETO FILED PURSUANT TO § 240.13d-2

    (Amendment No.         )*

     

     

    Outbrain Inc.

    (Name of Issuer)

    Common Stock, par value $0.001 per share

    (Title of Class of Securities)

    69002R103

    (CUSIP Number)

    December 31, 2021

    (Date of Event Which Requires Filing of this Statement)

     

     

     

    Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

     

      ☐

    Rule 13d-1(b)

     

      ☐

    Rule 13d-1(c)

     

      ☒

    Rule 13d-1(d)

     

    *

    The remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter disclosures provided in a prior cover page.

    The information required on the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).

     

     

     

     


    CUSIP NO. 69002R103   13 G   Page 2 of 14 Pages

     

      1    

      NAMES OF REPORTING PERSONS

     

      Gemini Israel IV Limited Partnership

     

      I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY):

      00-0000000

      2  

      CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (SEE INSTRUCTIONS)

      (a)  ☐        (b)  ☒(1)

     

      3  

      SEC USE ONLY

     

      4  

      CITIZENSHIP OR PLACE OF ORGANIZATION

     

      Israel

    NUMBER OF

    SHARES

     BENEFICIALLY 

    OWNED BY

    EACH

    REPORTING

    PERSON

    WITH

       5    

      SOLE VOTING POWER

     

      0

       6  

      SHARED VOTING POWER

     

      3,897,152

       7  

      SOLE DISPOSITIVE POWER

     

      0

       8  

      SHARED DISPOSITIVE POWER

     

      3,897,152

      9    

      AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

     

      3,897,152

    10  

      CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS)

     

      ☐

    11  

      PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9

     

      7.0% (2)

    12  

      TYPE OF REPORTING PERSON (SEE INSTRUCTIONS)

     

      PN

     

    (1)

    This Schedule 13G is filed on behalf of Gemini Israel IV Limited Partnership (“Gemini LP”), Gemini Israel IV (Annex Fund) Limited Partnership (“Gemini LP Annex”), Gemini Capital Associates IV L.P. (“Gemini Associates LP”), Gemini Capital Associates IV GP Ltd. (“Gemini Associates GP”), Gemini Partners Investors IV L.P. (“Gemini Partners”), Gemini Partners Investors IV (Annex Fund) L.P. (“Gemini Partners Annex”), Gemini Israel Funds IV Ltd. (“Gemini Israel”), Menashe Ezra (“Ezra”) and Yossi Sela (“Sela”) (collectively, the “Reporting Persons”). Gemini Associates GP is the general partner of Gemini Associates LP. Gemini Associates LP is the general partner of each of Gemini LP and Gemini LP Annex. Each of Gemini Associates GP and Gemini Associates LP may be deemed to beneficially own the common stock held by each of Gemini LP and Gemini LP Annex. Gemini Israel is the general partner of each of Gemini Partners and Gemini Partners Annex. Gemini Israel may be deemed to beneficially own the common stock held by each of the Gemini Partners and Gemini Partners Annex. Ezra and Sela are the managing partners of each of Gemini Associates GP and Gemini Israel and may be deemed to beneficially own the common stock held by each of Gemini LP, Gemini LP Annex, Gemini Partners and Gemini Partners Annex. Each of Gemini Associates GP and Gemini Associates LP hereby disclaims beneficial ownership of the common stock of the issuer held by Gemini LP and Gemini LP Annex except to the extent of its respective pecuniary interest therein. Gemini Israel hereby disclaims beneficial ownership of the common stock of the issuer held by Gemini Partners and Gemini Partners Annex except to the extent of its pecuniary interest therein. Each of Ezra and Sela hereby disclaims beneficial ownership of the common stock of the issuer held by the other Reporting Persons except to the extent of his pecuniary interest therein. The Reporting Persons may be deemed to a be a “group” for purposes of Section 13 of the Securities and Exchange Act of 1934 and hereby expressly disclaim status as a “group” for purposes of this Schedule 13G.

    (2)

    Based on 55,507,975 of the Issuer’s common stock outstanding as of November, 2021, as reported in the Issuer’s Quarterly Report on Form 10-Q for the quarterly period ended September 30, 2021, filed with the Securities and Exchange Commission on November 12, 2021.


    CUSIP NO. 69002R103   13 G   Page 3 of 14 Pages

     

      1    

      NAMES OF REPORTING PERSONS

     

      Gemini Israel IV (Annex Fund) Limited Partnership

     

      I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY):

      00-0000000

      2  

      CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (SEE INSTRUCTIONS)

      (a)  ☐        (b)  ☒ (1)

     

      3  

      SEC USE ONLY

     

      4  

      CITIZENSHIP OR PLACE OF ORGANIZATION

     

      Israel

    NUMBER OF

    SHARES

     BENEFICIALLY 

    OWNED BY

    EACH

    REPORTING

    PERSON

    WITH

       5    

      SOLE VOTING POWER

     

      0

       6  

      SHARED VOTING POWER

     

      950,658

       7  

      SOLE DISPOSITIVE POWER

     

      0

       8  

      SHARED DISPOSITIVE POWER

     

      950,658

      9    

      AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

     

      950,658

    10  

      CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS)

     

      ☐

    11  

      PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9

     

      1.7% (2)

    12  

      TYPE OF REPORTING PERSON (SEE INSTRUCTIONS)

     

      PN

     

    (1)

    This Schedule 13G is filed on behalf of Gemini Israel IV Limited Partnership (“Gemini LP”), Gemini Israel IV (Annex Fund) Limited Partnership (“Gemini LP Annex”), Gemini Capital Associates IV L.P. (“Gemini Associates LP”), Gemini Capital Associates IV GP Ltd. (“Gemini Associates GP”), Gemini Partners Investors IV L.P. (“Gemini Partners”), Gemini Partners Investors IV (Annex Fund) L.P. (“Gemini Partners Annex”), Gemini Israel Funds IV Ltd. (“Gemini Israel”), Menashe Ezra (“Ezra”) and Yossi Sela (“Sela”) (collectively, the “Reporting Persons”). Gemini Associates GP is the general partner of Gemini Associates LP. Gemini Associates LP is the general partner of each of Gemini LP and Gemini LP Annex. Each of Gemini Associates GP and Gemini Associates LP may be deemed to beneficially own the common stock held by each of Gemini LP and Gemini LP Annex. Gemini Israel is the general partner of each of Gemini Partners and Gemini Partners Annex. Gemini Israel may be deemed to beneficially own the common stock held by each of the Gemini Partners and Gemini Partners Annex. Ezra and Sela are the managing partners of each of Gemini Associates GP and Gemini Israel and may be deemed to beneficially own the common stock held by each of Gemini LP, Gemini LP Annex, Gemini Partners and Gemini Partners Annex. Each of Gemini Associates GP and Gemini Associates LP hereby disclaims beneficial ownership of the common stock of the issuer held by Gemini LP and Gemini LP Annex except to the extent of its respective pecuniary interest therein. Gemini Israel hereby disclaims beneficial ownership of the common stock of the issuer held by Gemini Partners and Gemini Partners Annex except to the extent of its pecuniary interest therein. Each of Ezra and Sela hereby disclaims beneficial ownership of the common stock of the issuer held by the other Reporting Persons except to the extent of his pecuniary interest therein. The Reporting Persons may be deemed to a be a “group” for purposes of Section 13 of the Securities and Exchange Act of 1934 and hereby expressly disclaim status as a “group” for purposes of this Schedule 13G.

    (2)

    Based on 55,507,975 of the Issuer’s common stock outstanding as of November, 2021, as reported in the Issuer’s Quarterly Report on Form 10-Q for the quarterly period ended September 30, 2021, filed with the Securities and Exchange Commission on November 12, 2021.


    CUSIP NO. 69002R103   13 G   Page 4 of 14 Pages

     

      1    

      NAMES OF REPORTING PERSONS

     

      Gemini Capital Associates IV L.P.

     

      I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY):

      00-0000000

      2  

      CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (SEE INSTRUCTIONS)

      (a)  ☐        (b)  ☒(1)

     

      3  

      SEC USE ONLY

     

      4  

      CITIZENSHIP OR PLACE OF ORGANIZATION

     

      Israel

    NUMBER OF

    SHARES

     BENEFICIALLY 

    OWNED BY

    EACH

    REPORTING

    PERSON

    WITH

       5    

      SOLE VOTING POWER

     

      0

       6  

      SHARED VOTING POWER

     

      4,847,810

       7  

      SOLE DISPOSITIVE POWER

     

      0

       8  

      SHARED DISPOSITIVE POWER

     

      4,847,810

      9    

      AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

     

      4,847,810

    10  

      CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS)

     

      ☐

    11  

      PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9

     

      8.7% (2)

    12  

      TYPE OF REPORTING PERSON (SEE INSTRUCTIONS)

     

      PN

     

    (1)

    This Schedule 13G is filed on behalf of Gemini Israel IV Limited Partnership (“Gemini LP”), Gemini Israel IV (Annex Fund) Limited Partnership (“Gemini LP Annex”), Gemini Capital Associates IV L.P. (“Gemini Associates LP”), Gemini Capital Associates IV GP Ltd. (“Gemini Associates GP”), Gemini Partners Investors IV L.P. (“Gemini Partners”), Gemini Partners Investors IV (Annex Fund) L.P. (“Gemini Partners Annex”), Gemini Israel Funds IV Ltd. (“Gemini Israel”), Menashe Ezra (“Ezra”) and Yossi Sela (“Sela”) (collectively, the “Reporting Persons”). Gemini Associates GP is the general partner of Gemini Associates LP. Gemini Associates LP is the general partner of each of Gemini LP and Gemini LP Annex. Each of Gemini Associates GP and Gemini Associates LP may be deemed to beneficially own the common stock held by each of Gemini LP and Gemini LP Annex. Gemini Israel is the general partner of each of Gemini Partners and Gemini Partners Annex. Gemini Israel may be deemed to beneficially own the common stock held by each of the Gemini Partners and Gemini Partners Annex. Ezra and Sela are the managing partners of each of Gemini Associates GP and Gemini Israel and may be deemed to beneficially own the common stock held by each of Gemini LP, Gemini LP Annex, Gemini Partners and Gemini Partners Annex. Each of Gemini Associates GP and Gemini Associates LP hereby disclaims beneficial ownership of the common stock of the issuer held by Gemini LP and Gemini LP Annex except to the extent of its respective pecuniary interest therein. Gemini Israel hereby disclaims beneficial ownership of the common stock of the issuer held by Gemini Partners and Gemini Partners Annex except to the extent of its pecuniary interest therein. Each of Ezra and Sela hereby disclaims beneficial ownership of the common stock of the issuer held by the other Reporting Persons except to the extent of his pecuniary interest therein. The Reporting Persons may be deemed to a be a “group” for purposes of Section 13 of the Securities and Exchange Act of 1934 and hereby expressly disclaim status as a “group” for purposes of this Schedule 13G.

    (2)

    Based on 55,507,975 of the Issuer’s common stock outstanding as of November, 2021, as reported in the Issuer’s Quarterly Report on Form 10-Q for the quarterly period ended September 30, 2021, filed with the Securities and Exchange Commission on November 12, 2021.


    CUSIP NO. 69002R103   13 G   Page 5 of 14 Pages

     

      1    

      NAMES OF REPORTING PERSONS

     

      Gemini Capital Associates IV GP Ltd.

     

      I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY):

      00-0000000

      2  

      CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (SEE INSTRUCTIONS)

      (a)  ☐        (b)  ☒(1)

     

      3  

      SEC USE ONLY

     

      4  

      CITIZENSHIP OR PLACE OF ORGANIZATION

     

      Israel

    NUMBER OF

    SHARES

     BENEFICIALLY 

    OWNED BY

    EACH

    REPORTING

    PERSON

    WITH

       5    

      SOLE VOTING POWER

     

      0

       6  

      SHARED VOTING POWER

     

      4,847,810

       7  

      SOLE DISPOSITIVE POWER

     

      0

       8  

      SHARED DISPOSITIVE POWER

     

      4,847,810

      9    

      AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

     

      4,847,810

    10  

      CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS)

     

      ☐

    11  

      PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9

     

      8.7% (2)

    12  

      TYPE OF REPORTING PERSON (SEE INSTRUCTIONS)

     

      OO

     

    (1)

    This Schedule 13G is filed on behalf of Gemini Israel IV Limited Partnership (“Gemini LP”), Gemini Israel IV (Annex Fund) Limited Partnership (“Gemini LP Annex”), Gemini Capital Associates IV L.P. (“Gemini Associates LP”), Gemini Capital Associates IV GP Ltd. (“Gemini Associates GP”), Gemini Partners Investors IV L.P. (“Gemini Partners”), Gemini Partners Investors IV (Annex Fund) L.P. (“Gemini Partners Annex”), Gemini Israel Funds IV Ltd. (“Gemini Israel”), Menashe Ezra (“Ezra”) and Yossi Sela (“Sela”) (collectively, the “Reporting Persons”). Gemini Associates GP is the general partner of Gemini Associates LP. Gemini Associates LP is the general partner of each of Gemini LP and Gemini LP Annex. Each of Gemini Associates GP and Gemini Associates LP may be deemed to beneficially own the common stock held by each of Gemini LP and Gemini LP Annex. Gemini Israel is the general partner of each of Gemini Partners and Gemini Partners Annex. Gemini Israel may be deemed to beneficially own the common stock held by each of the Gemini Partners and Gemini Partners Annex. Ezra and Sela are the managing partners of each of Gemini Associates GP and Gemini Israel and may be deemed to beneficially own the common stock held by each of Gemini LP, Gemini LP Annex, Gemini Partners and Gemini Partners Annex. Each of Gemini Associates GP and Gemini Associates LP hereby disclaims beneficial ownership of the common stock of the issuer held by Gemini LP and Gemini LP Annex except to the extent of its respective pecuniary interest therein. Gemini Israel hereby disclaims beneficial ownership of the common stock of the issuer held by Gemini Partners and Gemini Partners Annex except to the extent of its pecuniary interest therein. Each of Ezra and Sela hereby disclaims beneficial ownership of the common stock of the issuer held by the other Reporting Persons except to the extent of his pecuniary interest therein. The Reporting Persons may be deemed to a be a “group” for purposes of Section 13 of the Securities and Exchange Act of 1934 and hereby expressly disclaim status as a “group” for purposes of this Schedule 13G.

    (2)

    Based on 55,507,975 of the Issuer’s common stock outstanding as of November, 2021, as reported in the Issuer’s Quarterly Report on Form 10-Q for the quarterly period ended September 30, 2021, filed with the Securities and Exchange Commission on November 12, 2021.


    CUSIP NO. 69002R103   13 G   Page 6 of 14 Pages

     

      1    

      NAMES OF REPORTING PERSONS

     

      Gemini Partners Investors IV L.P.

     

      I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY):

      00-0000000

      2  

      CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (SEE INSTRUCTIONS)

      (a)  ☐        (b)  ☒(1)

     

      3  

      SEC USE ONLY

     

      4  

      CITIZENSHIP OR PLACE OF ORGANIZATION

     

      Israel

    NUMBER OF

    SHARES

     BENEFICIALLY 

    OWNED BY

    EACH

    REPORTING

    PERSON

    WITH

       5    

      SOLE VOTING POWER

     

      0

       6  

      SHARED VOTING POWER

     

      39,365

       7  

      SOLE DISPOSITIVE POWER

     

      0

       8  

      SHARED DISPOSITIVE POWER

     

      39,365

      9    

      AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

     

      39,365

    10  

      CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS)

     

      ☐

    11  

      PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9

     

      .1% (2)

    12  

      TYPE OF REPORTING PERSON (SEE INSTRUCTIONS)

     

      PN

     

    (1)

    This Schedule 13G is filed on behalf of Gemini Israel IV Limited Partnership (“Gemini LP”), Gemini Israel IV (Annex Fund) Limited Partnership (“Gemini LP Annex”), Gemini Capital Associates IV L.P. (“Gemini Associates LP”), Gemini Capital Associates IV GP Ltd. (“Gemini Associates GP”), Gemini Partners Investors IV L.P. (“Gemini Partners”), Gemini Partners Investors IV (Annex Fund) L.P. (“Gemini Partners Annex”), Gemini Israel Funds IV Ltd. (“Gemini Israel”), Menashe Ezra (“Ezra”) and Yossi Sela (“Sela”) (collectively, the “Reporting Persons”). Gemini Associates GP is the general partner of Gemini Associates LP. Gemini Associates LP is the general partner of each of Gemini LP and Gemini LP Annex. Each of Gemini Associates GP and Gemini Associates LP may be deemed to beneficially own the common stock held by each of Gemini LP and Gemini LP Annex. Gemini Israel is the general partner of each of Gemini Partners and Gemini Partners Annex. Gemini Israel may be deemed to beneficially own the common stock held by each of the Gemini Partners and Gemini Partners Annex. Ezra and Sela are the managing partners of each of Gemini Associates GP and Gemini Israel and may be deemed to beneficially own the common stock held by each of Gemini LP, Gemini LP Annex, Gemini Partners and Gemini Partners Annex. Each of Gemini Associates GP and Gemini Associates LP hereby disclaims beneficial ownership of the common stock of the issuer held by Gemini LP and Gemini LP Annex except to the extent of its respective pecuniary interest therein. Gemini Israel hereby disclaims beneficial ownership of the common stock of the issuer held by Gemini Partners and Gemini Partners Annex except to the extent of its pecuniary interest therein. Each of Ezra and Sela hereby disclaims beneficial ownership of the common stock of the issuer held by the other Reporting Persons except to the extent of his pecuniary interest therein. The Reporting Persons may be deemed to a be a “group” for purposes of Section 13 of the Securities and Exchange Act of 1934 and hereby expressly disclaim status as a “group” for purposes of this Schedule 13G.

    (2)

    Based on 55,507,975 of the Issuer’s common stock outstanding as of November, 2021, as reported in the Issuer’s Quarterly Report on Form 10-Q for the quarterly period ended September 30, 2021, filed with the Securities and Exchange Commission on November 12, 2021.


    CUSIP NO. 69002R103   13 G   Page 7 of 14 Pages

     

      1    

      NAMES OF REPORTING PERSONS

     

      Gemini Partners Investors IV (Annex Fund) L.P.

     

      I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY):

      00-0000000

      2  

      CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (SEE INSTRUCTIONS)

      (a)  ☐        (b)  ☒(1)

     

      3  

      SEC USE ONLY

     

      4  

      CITIZENSHIP OR PLACE OF ORGANIZATION

     

      Israel

    NUMBER OF

    SHARES

     BENEFICIALLY 

    OWNED BY

    EACH

    REPORTING

    PERSON

    WITH

       5    

      SOLE VOTING POWER

     

      0

       6  

      SHARED VOTING POWER

     

      34,588

       7  

      SOLE DISPOSITIVE POWER

     

      0

       8  

      SHARED DISPOSITIVE POWER

     

      34,588

      9    

      AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

     

      34,588

    10  

      CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS)

     

      ☐

    11  

      PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9

     

      .1% (2)

    12  

      TYPE OF REPORTING PERSON (SEE INSTRUCTIONS)

     

      PN

     

    (1)

    This Schedule 13G is filed on behalf of Gemini Israel IV Limited Partnership (“Gemini LP”), Gemini Israel IV (Annex Fund) Limited Partnership (“Gemini LP Annex”), Gemini Capital Associates IV L.P. (“Gemini Associates LP”), Gemini Capital Associates IV GP Ltd. (“Gemini Associates GP”), Gemini Partners Investors IV L.P. (“Gemini Partners”), Gemini Partners Investors IV (Annex Fund) L.P. (“Gemini Partners Annex”), Gemini Israel Funds IV Ltd. (“Gemini Israel”), Menashe Ezra (“Ezra”) and Yossi Sela (“Sela”) (collectively, the “Reporting Persons”). Gemini Associates GP is the general partner of Gemini Associates LP. Gemini Associates LP is the general partner of each of Gemini LP and Gemini LP Annex. Each of Gemini Associates GP and Gemini Associates LP may be deemed to beneficially own the common stock held by each of Gemini LP and Gemini LP Annex. Gemini Israel is the general partner of each of Gemini Partners and Gemini Partners Annex. Gemini Israel may be deemed to beneficially own the common stock held by each of the Gemini Partners and Gemini Partners Annex. Ezra and Sela are the managing partners of each of Gemini Associates GP and Gemini Israel and may be deemed to beneficially own the common stock held by each of Gemini LP, Gemini LP Annex, Gemini Partners and Gemini Partners Annex. Each of Gemini Associates GP and Gemini Associates LP hereby disclaims beneficial ownership of the common stock of the issuer held by Gemini LP and Gemini LP Annex except to the extent of its respective pecuniary interest therein. Gemini Israel hereby disclaims beneficial ownership of the common stock of the issuer held by Gemini Partners and Gemini Partners Annex except to the extent of its pecuniary interest therein. Each of Ezra and Sela hereby disclaims beneficial ownership of the common stock of the issuer held by the other Reporting Persons except to the extent of his pecuniary interest therein. The Reporting Persons may be deemed to a be a “group” for purposes of Section 13 of the Securities and Exchange Act of 1934 and hereby expressly disclaim status as a “group” for purposes of this Schedule 13G.

    (2)

    Based on 55,507,975 of the Issuer’s common stock outstanding as of November, 2021, as reported in the Issuer’s Quarterly Report on Form 10-Q for the quarterly period ended September 30, 2021, filed with the Securities and Exchange Commission on November 12, 2021.


    CUSIP NO. 69002R103   13 G   Page 8 of 14 Pages

     

      1    

      NAMES OF REPORTING PERSONS

     

      Gemini Israel Funds IV Ltd.

     

      I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY):

      00-0000000

      2  

      CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (SEE INSTRUCTIONS)

      (a)  ☐        (b)  ☒(1)

     

      3  

      SEC USE ONLY

     

      4  

      CITIZENSHIP OR PLACE OF ORGANIZATION

     

      Israel

    NUMBER OF

    SHARES

     BENEFICIALLY 

    OWNED BY

    EACH

    REPORTING

    PERSON

    WITH

       5    

      SOLE VOTING POWER

     

      0

       6  

      SHARED VOTING POWER

     

      73,953

       7  

      SOLE DISPOSITIVE POWER

     

      0

       8  

      SHARED DISPOSITIVE POWER

     

      73,953

      9    

      AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

     

      73,953

    10  

      CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS)

     

      ☐

    11  

      PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9

     

      0.1% (2)

    12  

      TYPE OF REPORTING PERSON (SEE INSTRUCTIONS)

     

      OO

     

    (1)

    This Schedule 13G is filed on behalf of Gemini Israel IV Limited Partnership (“Gemini LP”), Gemini Israel IV (Annex Fund) Limited Partnership (“Gemini LP Annex”), Gemini Capital Associates IV L.P. (“Gemini Associates LP”), Gemini Capital Associates IV GP Ltd. (“Gemini Associates GP”), Gemini Partners Investors IV L.P. (“Gemini Partners”), Gemini Partners Investors IV (Annex Fund) L.P. (“Gemini Partners Annex”), Gemini Israel Funds IV Ltd. (“Gemini Israel”), Menashe Ezra (“Ezra”) and Yossi Sela (“Sela”) (collectively, the “Reporting Persons”). Gemini Associates GP is the general partner of Gemini Associates LP. Gemini Associates LP is the general partner of each of Gemini LP and Gemini LP Annex. Each of Gemini Associates GP and Gemini Associates LP may be deemed to beneficially own the common stock held by each of Gemini LP and Gemini LP Annex. Gemini Israel is the general partner of each of Gemini Partners and Gemini Partners Annex. Gemini Israel may be deemed to beneficially own the common stock held by each of the Gemini Partners and Gemini Partners Annex. Ezra and Sela are the managing partners of each of Gemini Associates GP and Gemini Israel and may be deemed to beneficially own the common stock held by each of Gemini LP, Gemini LP Annex, Gemini Partners and Gemini Partners Annex. Each of Gemini Associates GP and Gemini Associates LP hereby disclaims beneficial ownership of the common stock of the issuer held by Gemini LP and Gemini LP Annex except to the extent of its respective pecuniary interest therein. Gemini Israel hereby disclaims beneficial ownership of the common stock of the issuer held by Gemini Partners and Gemini Partners Annex except to the extent of its pecuniary interest therein. Each of Ezra and Sela hereby disclaims beneficial ownership of the common stock of the issuer held by the other Reporting Persons except to the extent of his pecuniary interest therein. The Reporting Persons may be deemed to a be a “group” for purposes of Section 13 of the Securities and Exchange Act of 1934 and hereby expressly disclaim status as a “group” for purposes of this Schedule 13G.

    (2)

    Based on 55,507,975 of the Issuer’s common stock outstanding as of November, 2021, as reported in the Issuer’s Quarterly Report on Form 10-Q for the quarterly period ended September 30, 2021, filed with the Securities and Exchange Commission on November 12, 2021.


    CUSIP NO. 69002R103   13 G   Page 9 of 14 Pages

     

      1    

      NAMES OF REPORTING PERSONS

     

      Menashe Ezra

      2  

      CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (SEE INSTRUCTIONS)

      (a)  ☐        (b)  ☒(1)

     

      3  

      SEC USE ONLY

     

      4  

      CITIZENSHIP OR PLACE OF ORGANIZATION

     

      Israel

    NUMBER OF

    SHARES

     BENEFICIALLY 

    OWNED BY

    EACH

    REPORTING

    PERSON

    WITH

       5    

      SOLE VOTING POWER

     

      0

       6  

      SHARED VOTING POWER

     

      4,921,763

       7  

      SOLE DISPOSITIVE POWER

     

      0

       8  

      SHARED DISPOSITIVE POWER

     

      4,921,763

      9    

      AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

     

      4,921,763

    10  

      CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS)

     

      ☐

    11  

      PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9

     

      8.9% (2)

    12  

      TYPE OF REPORTING PERSON (SEE INSTRUCTIONS)

     

      IN

     

    (1)

    This Schedule 13G is filed on behalf of Gemini Israel IV Limited Partnership (“Gemini LP”), Gemini Israel IV (Annex Fund) Limited Partnership (“Gemini LP Annex”), Gemini Capital Associates IV L.P. (“Gemini Associates LP”), Gemini Capital Associates IV GP Ltd. (“Gemini Associates GP”), Gemini Partners Investors IV L.P. (“Gemini Partners”), Gemini Partners Investors IV (Annex Fund) L.P. (“Gemini Partners Annex”), Gemini Israel Funds IV Ltd. (“Gemini Israel”), Menashe Ezra (“Ezra”) and Yossi Sela (“Sela”) (collectively, the “Reporting Persons”). Gemini Associates GP is the general partner of Gemini Associates LP. Gemini Associates LP is the general partner of each of Gemini LP and Gemini LP Annex. Each of Gemini Associates GP and Gemini Associates LP may be deemed to beneficially own the common stock held by each of Gemini LP and Gemini LP Annex. Gemini Israel is the general partner of each of Gemini Partners and Gemini Partners Annex. Gemini Israel may be deemed to beneficially own the common stock held by each of the Gemini Partners and Gemini Partners Annex. Ezra and Sela are the managing partners of each of Gemini Associates GP and Gemini Israel and may be deemed to beneficially own the common stock held by each of Gemini LP, Gemini LP Annex, Gemini Partners and Gemini Partners Annex. Each of Gemini Associates GP and Gemini Associates LP hereby disclaims beneficial ownership of the common stock of the issuer held by Gemini LP and Gemini LP Annex except to the extent of its respective pecuniary interest therein. Gemini Israel hereby disclaims beneficial ownership of the common stock of the issuer held by Gemini Partners and Gemini Partners Annex except to the extent of its pecuniary interest therein. Each of Ezra and Sela hereby disclaims beneficial ownership of the common stock of the issuer held by the other Reporting Persons except to the extent of his pecuniary interest therein. The Reporting Persons may be deemed to a be a “group” for purposes of Section 13 of the Securities and Exchange Act of 1934 and hereby expressly disclaim status as a “group” for purposes of this Schedule 13G.

    (2)

    Based on 55,507,975 of the Issuer’s common stock outstanding as of November, 2021, as reported in the Issuer’s Quarterly Report on Form 10-Q for the quarterly period ended September 30, 2021, filed with the Securities and Exchange Commission on November 12, 2021.


    CUSIP NO. 69002R103   13 G   Page 10 of 14 Pages

     

      1    

      NAMES OF REPORTING PERSONS

     

      Yossi Sela

      2  

      CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (SEE INSTRUCTIONS)

      (a)  ☐        (b)  ☒(1)

     

      3  

      SEC USE ONLY

     

      4  

      CITIZENSHIP OR PLACE OF ORGANIZATION

     

      Israel

    NUMBER OF

    SHARES

     BENEFICIALLY 

    OWNED BY

    EACH

    REPORTING

    PERSON

    WITH

       5    

      SOLE VOTING POWER

     

      0

       6  

      SHARED VOTING POWER

     

      4,921,763

       7  

      SOLE DISPOSITIVE POWER

     

      0

       8  

      SHARED DISPOSITIVE POWER

     

      4,921,763

      9    

      AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

     

      4,921,763

    10  

      CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS)

     

      ☐

    11  

      PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9

     

      8.9% (2)

    12  

      TYPE OF REPORTING PERSON (SEE INSTRUCTIONS)

     

      IN

     

    (1)

    This Schedule 13G is filed on behalf of Gemini Israel IV Limited Partnership (“Gemini LP”), Gemini Israel IV (Annex Fund) Limited Partnership (“Gemini LP Annex”), Gemini Capital Associates IV L.P. (“Gemini Associates LP”), Gemini Capital Associates IV GP Ltd. (“Gemini Associates GP”), Gemini Partners Investors IV L.P. (“Gemini Partners”), Gemini Partners Investors IV (Annex Fund) L.P. (“Gemini Partners Annex”), Gemini Israel Funds IV Ltd. (“Gemini Israel”), Menashe Ezra (“Ezra”) and Yossi Sela (“Sela”) (collectively, the “Reporting Persons”). Gemini Associates GP is the general partner of Gemini Associates LP. Gemini Associates LP is the general partner of each of Gemini LP and Gemini LP Annex. Each of Gemini Associates GP and Gemini Associates LP may be deemed to beneficially own the common stock held by each of Gemini LP and Gemini LP Annex. Gemini Israel is the general partner of each of Gemini Partners and Gemini Partners Annex. Gemini Israel may be deemed to beneficially own the common stock held by each of the Gemini Partners and Gemini Partners Annex. Ezra and Sela are the managing partners of each of Gemini Associates GP and Gemini Israel and may be deemed to beneficially own the common stock held by each of Gemini LP, Gemini LP Annex, Gemini Partners and Gemini Partners Annex. Each of Gemini Associates GP and Gemini Associates LP hereby disclaims beneficial ownership of the common stock of the issuer held by Gemini LP and Gemini LP Annex except to the extent of its respective pecuniary interest therein. Gemini Israel hereby disclaims beneficial ownership of the common stock of the issuer held by Gemini Partners and Gemini Partners Annex except to the extent of its pecuniary interest therein. Each of Ezra and Sela hereby disclaims beneficial ownership of the common stock of the issuer held by the other Reporting Persons except to the extent of his pecuniary interest therein. The Reporting Persons may be deemed to a be a “group” for purposes of Section 13 of the Securities and Exchange Act of 1934 and hereby expressly disclaim status as a “group” for purposes of this Schedule 13G.

    (2)

    Based on 55,507,975 of the Issuer’s common stock outstanding as of November, 2021, as reported in the Issuer’s Quarterly Report on Form 10-Q for the quarterly period ended September 30, 2021, filed with the Securities and Exchange Commission on November 12, 2021.


    CUSIP NO. 69002R103   13 G   Page 11 of 14 Pages

     

    Item 1(a)

    Name of Issuer:

    Outbrain Inc.

     

    Item 1(b)

    Address of Issuer’s principal executive offices:

    111 West 19th Street

    New York, NY 10011

     

    Items 2(a)

    Name of Reporting Persons filing:

    Each of the following is a reporting person (“Reporting Person”):

    Gemini Israel IV Limited Partnership

    Gemini Israel IV (Annex Fund) Limited Partnership

    Gemini Capital Associates IV L.P.

    Gemini Capital Associates IV GP Ltd.

    Gemini Partners Investors IV L.P.

    Gemini Partners Investors IV (Annex Fund) L.P.

    Gemini Israel Funds IV Ltd.

    Menashe Ezra

    Yossi Sela

     

    Item 2(b)

    Address or principal business office or, if none, residence:

    The principal business address of each Reporting Person is:

    c/o Gemini Israel Ventures

    1 Abba Eban Avenue

    Merkazim 2001, Bldg A, 3rd Floor

    Herzliya Israel

     

    Item 2(c)

    Citizenship:

    Reference is made to the response to item 4 on each of pages 2-7 of this Schedule 13G (this “Schedule”), which responses are incorporated herein by reference.

     

    Item 2(d)

    Title of class of securities:

    Common Stock, par value $0.001 per share

     

    Item 2(e)

    CUSIP No.:

    69002R103

     

    Item 3

    If this statement is filed pursuant to §§ 240.13d-1(b), or 240.13d-2(b) or (c), check whether the person filings is a:

    Not applicable.


    CUSIP NO. 69002R103   13 G   Page 12 of 14 Pages

     

    Item 4

    Ownership

    Reference is hereby made to the responses to items 5-9 and 11 of pages 2 – 10 of this Schedule, which responses are incorporated by reference herein.

    Gemini Associates GP is the general partner of Gemini Associates LP. Gemini Associates LP is the general partner of each of Gemini LP and Gemini LP Annex. Gemini Israel is the general partner and/or controlling partner of each of Gemini Partners and Gemini Partners Annex. Ezra and Sela are the Managing Partners of each of Gemini Associates GP and Gemini Israel. Each of Gemini Associates GP and Gemini Associates LP hereby disclaims beneficial ownership of the common stock of the issuer held by each of Gemini LP and Gemini LP Annex except to the extent of its pecuniary interest therein. Gemini Israel hereby disclaims beneficial ownership of the common stock of the issuer held by each of Gemini Partners and Gemini Partners Annex except to the extent of its pecuniary interest therein. Each of Ezra and Sela hereby disclaims beneficial ownership of the common stock of the issuer held by each of Gemini LP, Gemini LP Annex, Gemini Partners and Gemini Partners Annex except to the extent of his pecuniary interest therein.

     

    Item 5

    Ownership of Five Percent or Less of a Class

    If this statement is being filed to report the fact that as of the date hereof the reporting person has ceased to be the beneficial owner of more than five percent of the class of securities, check the following:    ☐

     

    Item 6

    Ownership of More than Five Percent on Behalf of Another Person

    Not applicable.

     

    Item 7

    Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company or Control Person

    Not applicable.

     

    Item 8

    Identification and Classification of Members of the Group

    Not applicable.

     

    Item 9

    Notice of Dissolution of Group

    Not applicable.

     

    Item 10

    Certifications

    Not applicable.


    SIGNATURES

    After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

    Dated: February 7, 2022

     

    GEMINI ISRAEL IV LIMITED PARTNERSHIP
    By: GEMINI CAPITAL ASSOCIATES IV L.P.

    Its: General Partner,

    for itself and as general partner of Gemini Israel IV

    Limited Partnership

    By: GEMINI CAPITAL ASSOCIATES IV GP Ltd.

    Its: General Partner,

    for itself and as general partner of Gemini Capital

    Associates IV L.P.

     

    By:   

    /s/ Yossi Sela

                       By:   

    /s/ Menashe Ezra

    Name:    Yossi Sela       Name:    Menashe Ezra
    Title:    Managing Partner       Title:    Managing Partner

     

    GEMINI ISRAEL IV (ANNEX FUND) Limited Partnership

    By: GEMINI CAPITAL ASSOCIATES IV L.P.

    Its: General Partner,

    for itself and as general partner of Gemini Israel IV

    (Annex Fund) Limited Partnership

    By: GEMINI CAPITAL ASSOCIATES IV GP Ltd.

    Its: General Partner,

    for itself and as general partner of Gemini Capital

    Associates IV L.P.

     

    By:   

    /s/ Yossi Sela

                       By:   

    /s/ Menashe Ezra

    Name:    Yossi Sela       Name:    Menashe Ezra
    Title:    Managing Partner       Title:    Managing Partner

     

    GEMINI PARTNERS INVESTORS IV L.P.
    By: GEMINI ISRAEL FUNDS IV LTD.

    Its: General Partner,

    for itself and as general partner of Gemini Partners

    Investors IV L.P.

     

    By:   

    /s/ Yossi Sela

                       By:   

    /s/ Menashe Ezra

    Name:    Yossi Sela       Name:    Menashe Ezra
    Title:    Managing Partner       Title:    Managing Partner


    GEMINI PARTNERS INVESTORS IV (ANNEX FUND) L.P.
    By: GEMINI ISRAEL FUNDS IV LTD.

    Its: General Partner,

    for itself and as general partner of Gemini Partners

    Investors IV (Annex Fund) L.P.

     

    By:   

    /s/ Yossi Sela

                       By:   

    /s/ Menashe Ezra

    Name:    Yossi Sela       Name:    Menashe Ezra
    Title:    Managing Partner       Title:    Managing Partner

    /s/ Menashe Ezra

            
    Menashe Ezra         

    /s/ Yossi Sela

            
    Yossi Sela         
    Get the next $OB alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $OB

    DatePrice TargetRatingAnalyst
    5/2/2024$4.00Hold
    Jefferies
    4/24/2024$4.50Neutral
    B. Riley Securities
    6/22/2023$5.00Neutral
    B. Riley Securities
    12/16/2022$7.00 → $4.50Buy
    Needham
    12/13/2022$4.00Neutral
    Citigroup
    11/11/2022$6.50 → $4.00Buy → Hold
    Jefferies
    5/13/2022$9.00Outperform → In-line
    Evercore ISI
    5/6/2022$16.00 → $14.00Buy
    Jefferies
    More analyst ratings

    $OB
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    CAO & SVP Corporate Controller Bradshaw Wenkai covered exercise/tax liability with 2,309 shares, decreasing direct ownership by 2% to 123,381 units (SEC Form 4)

    4 - Teads Holding Co. (0001454938) (Issuer)

    6/10/25 4:32:07 PM ET
    $OB
    Computer Software: Programming Data Processing
    Technology

    Chief Executive Officer Kostman David covered exercise/tax liability with 55,788 shares, decreasing direct ownership by 4% to 1,253,152 units (SEC Form 4)

    4 - Teads Holding Co. (0001454938) (Issuer)

    6/10/25 4:31:54 PM ET
    $OB
    Computer Software: Programming Data Processing
    Technology

    Chief Financial Officer Kiviat Jason covered exercise/tax liability with 9,185 shares, decreasing direct ownership by 4% to 249,129 units (SEC Form 4)

    4 - Teads Holding Co. (0001454938) (Issuer)

    6/10/25 4:31:43 PM ET
    $OB
    Computer Software: Programming Data Processing
    Technology

    $OB
    SEC Filings

    View All

    Outbrain Inc. filed SEC Form 8-K: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Regulation FD Disclosure, Other Events, Financial Statements and Exhibits

    8-K - Outbrain Inc. (0001454938) (Filer)

    6/9/25 6:03:28 AM ET
    $OB
    Computer Software: Programming Data Processing
    Technology

    Outbrain Inc. filed SEC Form 8-K: Submission of Matters to a Vote of Security Holders

    8-K - Outbrain Inc. (0001454938) (Filer)

    6/6/25 4:47:50 PM ET
    $OB
    Computer Software: Programming Data Processing
    Technology

    Outbrain Inc. filed SEC Form 8-K: Other Events, Financial Statements and Exhibits

    8-K - Outbrain Inc. (0001454938) (Filer)

    6/3/25 4:33:37 PM ET
    $OB
    Computer Software: Programming Data Processing
    Technology

    $OB
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Jefferies resumed coverage on Outbrain Inc. with a new price target

    Jefferies resumed coverage of Outbrain Inc. with a rating of Hold and set a new price target of $4.00

    5/2/24 6:30:57 AM ET
    $OB
    Computer Software: Programming Data Processing
    Technology

    B. Riley Securities resumed coverage on Outbrain Inc. with a new price target

    B. Riley Securities resumed coverage of Outbrain Inc. with a rating of Neutral and set a new price target of $4.50

    4/24/24 8:03:35 AM ET
    $OB
    Computer Software: Programming Data Processing
    Technology

    B. Riley Securities initiated coverage on Outbrain Inc. with a new price target

    B. Riley Securities initiated coverage of Outbrain Inc. with a rating of Neutral and set a new price target of $5.00

    6/22/23 7:35:41 AM ET
    $OB
    Computer Software: Programming Data Processing
    Technology

    $OB
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Chief Executive Officer Kostman David bought $79,600 worth of shares (20,000 units at $3.98), increasing direct ownership by 2% to 828,940 units (SEC Form 4)

    4 - Outbrain Inc. (0001454938) (Issuer)

    3/17/25 4:57:55 PM ET
    $OB
    Computer Software: Programming Data Processing
    Technology

    $OB
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Outbrain Completes Change of Corporate Name to Teads

    NEW YORK, June 09, 2025 (GLOBE NEWSWIRE) -- Outbrain Inc. (NASDAQ:OB), which is operating under the new Teads brand following Outbrain's acquisition of Teads in February 2025, announced today that the combined company has completed its corporate renaming from "Outbrain Inc." to "Teads Holding Co." The combined company will begin trading under the new ticker symbol "TEAD" on the Nasdaq effective June 10, 2025. "The name change is an important milestone to complete the combined company's rebrand," said David Kostman, Teads CEO. "Teads is now one of the largest platforms on the premium open internet, combining the legacy companies' strengths in performance and branding into an end-to-end pla

    6/9/25 7:00:50 AM ET
    $OB
    Computer Software: Programming Data Processing
    Technology

    Outbrain Announces First Quarter 2025 Results

    NEW YORK, May 09, 2025 (GLOBE NEWSWIRE) -- Outbrain Inc. (NASDAQ:OB), which is operating under the new Teads brand following Outbrain's acquisition of Teads in February 2025, announced today financial results for the quarter ended March 31, 2025. First Quarter 2025 Key Financial Metrics1:  Three Months Ended March 31,(in millions USD) 2025   2024  % ChangeRevenue$286.4  $217.0  32 %Gross profit 82.7   41.6  99 %Net loss (54.8)  (5.0) NMNet cash (used in) provided by operating activities (1.0)  8.6  (111)%      Non-GAAP Financial Data*     Ex-TAC gross profit 103.1   52.2  98 %Adjusted EBITDA 10.7   1.4  665 %Adjusted net loss (15.3)  (4.9) (211)%Free cash flow (6.6)  4.6  (242)% _________

    5/9/25 6:30:43 AM ET
    $OB
    Computer Software: Programming Data Processing
    Technology

    Outbrain to Release First Quarter 2025 Financial Results on May 9, 2025

    NEW YORK, April 29, 2025 (GLOBE NEWSWIRE) -- Outbrain Inc. (NASDAQ:OB), which is operating under the new Teads brand, announced today that the company will release its first quarter 2025 results before the market opens on Friday, May 9, 2025, followed by a conference call at 8:30 a.m. (Eastern Time) that same day to discuss the company's results and business outlook. The conference call can be accessed live over the phone by dialing 1-877-497-9071 or for international callers, 1-201-689-8727. A replay will be available two hours after the call and can be accessed by dialing 1-877-660-6853, or for international callers, 1-201-612-7415. The passcode for the live call and replay is 13753068.

    4/29/25 8:30:00 AM ET
    $OB
    Computer Software: Programming Data Processing
    Technology

    $OB
    Leadership Updates

    Live Leadership Updates

    View All

    Outbrain Names Greg Archibald as GM & SVP of Sales, US

    NEW YORK, June 11, 2024 (GLOBE NEWSWIRE) -- Outbrain, a leading technology platform that drives business results by engaging people across the open internet, today announced the appointment of Greg Archibald as General Manager & Senior Vice President of Sales for the United States. In this role, Archibald will oversee all agency and brand demand functions in the US, with a focus on driving revenue, adoption, and retention of Outbrain's high-impact performance advertising solutions, including the open internet branding platform, Onyx by Outbrain. Archibald brings over two decades of experience leading high-performing sales teams for companies including Criteo, Yahoo, and InMobi. His strate

    6/11/24 9:00:14 AM ET
    $OB
    Computer Software: Programming Data Processing
    Technology

    Outbrain Announces Senior Leadership Appointments

    NEW YORK, May 04, 2023 (GLOBE NEWSWIRE) -- Outbrain Inc. (NASDAQ:OB), a leading recommendation platform for the open web, today announced key promotions to scale global operations, drive innovation, and expand Outbrain's offerings for brands, advertisers, and publishers. These appointments follow Alexander Erlmeier's promotion to Chief Revenue Officer in October 2022. "Evolving customer habits and emerging technologies continue to necessitate agility and resiliency among technology and advertising organizations," said Erlmeier. "With an expanded and unified leadership team, Outbrain is well positioned to scale alongside the evolving industry. Together with our teams across the globe, our

    5/4/23 9:00:00 AM ET
    $OB
    Computer Software: Programming Data Processing
    Technology

    Outbrain Bolsters Senior Team with Two C-Suite Appointments

    NEW YORK, April 20, 2023 (GLOBE NEWSWIRE) -- Outbrain Inc. (NASDAQ:OB), a leading recommendation platform for the open web, today announced the appointment of Yonatan Maman as Chief Technology Officer and Andraz Tori in a newly created executive role as Chief Product Officer. Co-Founder, Chief Technology Officer, and General Manager, Israel, Ori Lahav, will transition his responsibilities and focus on cross-company strategic initiatives, while continuing his role as General Manager, Israel. The newly-appointed executives will support Outbrain's growth by building upon the company's existing technologies and product offerings to align with the evolving needs of publishers, brands, an

    4/20/23 9:00:00 AM ET
    $OB
    Computer Software: Programming Data Processing
    Technology

    $OB
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13G/A filed by Outbrain Inc.

    SC 13G/A - Outbrain Inc. (0001454938) (Subject)

    11/7/24 1:24:20 PM ET
    $OB
    Computer Software: Programming Data Processing
    Technology

    Amendment: SEC Form SC 13G/A filed by Outbrain Inc.

    SC 13G/A - Outbrain Inc. (0001454938) (Subject)

    10/4/24 4:00:22 PM ET
    $OB
    Computer Software: Programming Data Processing
    Technology

    SEC Form SC 13G filed by Outbrain Inc.

    SC 13G - Outbrain Inc. (0001454938) (Subject)

    8/7/24 1:45:46 PM ET
    $OB
    Computer Software: Programming Data Processing
    Technology

    $OB
    Financials

    Live finance-specific insights

    View All

    Outbrain Announces First Quarter 2025 Results

    NEW YORK, May 09, 2025 (GLOBE NEWSWIRE) -- Outbrain Inc. (NASDAQ:OB), which is operating under the new Teads brand following Outbrain's acquisition of Teads in February 2025, announced today financial results for the quarter ended March 31, 2025. First Quarter 2025 Key Financial Metrics1:  Three Months Ended March 31,(in millions USD) 2025   2024  % ChangeRevenue$286.4  $217.0  32 %Gross profit 82.7   41.6  99 %Net loss (54.8)  (5.0) NMNet cash (used in) provided by operating activities (1.0)  8.6  (111)%      Non-GAAP Financial Data*     Ex-TAC gross profit 103.1   52.2  98 %Adjusted EBITDA 10.7   1.4  665 %Adjusted net loss (15.3)  (4.9) (211)%Free cash flow (6.6)  4.6  (242)% _________

    5/9/25 6:30:43 AM ET
    $OB
    Computer Software: Programming Data Processing
    Technology

    Outbrain to Release First Quarter 2025 Financial Results on May 9, 2025

    NEW YORK, April 29, 2025 (GLOBE NEWSWIRE) -- Outbrain Inc. (NASDAQ:OB), which is operating under the new Teads brand, announced today that the company will release its first quarter 2025 results before the market opens on Friday, May 9, 2025, followed by a conference call at 8:30 a.m. (Eastern Time) that same day to discuss the company's results and business outlook. The conference call can be accessed live over the phone by dialing 1-877-497-9071 or for international callers, 1-201-689-8727. A replay will be available two hours after the call and can be accessed by dialing 1-877-660-6853, or for international callers, 1-201-612-7415. The passcode for the live call and replay is 13753068.

    4/29/25 8:30:00 AM ET
    $OB
    Computer Software: Programming Data Processing
    Technology

    Outbrain Announces Fourth Quarter and Full Year 2024 Results

    Reports another quarter of accelerated growth and profitability, achieved Q4 guidance on Ex TAC gross profit and Adjusted EBITDA, and generated strong cash flow Closed acquisition of Teads in February 2025; Combined company operating under the name Teads NEW YORK, Feb. 27, 2025 (GLOBE NEWSWIRE) -- Outbrain Inc. (NASDAQ:OB), which is operating under the new Teads brand, announced today financial results for the quarter and full year ended December 31, 2024. Fourth Quarter and Full Year 2024 Key Financial Metrics:  Three Months EndedDecember 31, Twelve Months EndedDecember 31,(in millions USD) 2024   2023  % Change  2024   2023  % ChangeRevenue$234.6  $248.2   (5)% $889.9  $935.8   (5)%Gr

    2/27/25 6:30:48 AM ET
    $OB
    Computer Software: Programming Data Processing
    Technology